Page last updated: 2024-08-24

telmisartan and AIDS Seroconversion

telmisartan has been researched along with AIDS Seroconversion in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hampson, LV; Jaki, T1
De Caterina, R; Di Iorio, A; Falasca, K; Mancino, P; Ucciferri, C; Vecchiet, J1

Other Studies

2 other study(ies) available for telmisartan and AIDS Seroconversion

ArticleYear
Designing multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection.
    Statistics in medicine, 2016, Feb-20, Volume: 35, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Clinical Trials, Phase III as Topic; Computer Simulation; Decision Making; Endpoint Determination; HIV Seropositivity; Humans; Insulin Resistance; Models, Statistical; Patient Safety; Research Design; Sample Size; Telmisartan

2016
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients.
    Antiviral therapy, 2011, Volume: 16, Issue:5

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Cystatin C; Endothelin-1; HIV Seropositivity; Humans; Hypertension; Insulin Resistance; Interleukin-18; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; PPAR gamma; Risk Factors; Telmisartan; Triglycerides

2011
chemdatabank.com